These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 7520751)

  • 1. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization.
    Pantoliano MW; Horlick RA; Springer BA; Van Dyk DE; Tobery T; Wetmore DR; Lear JD; Nahapetian AT; Bradley JD; Sisk WP
    Biochemistry; 1994 Aug; 33(34):10229-48. PubMed ID: 7520751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling studies on binding of bFGF to heparin and its receptor FGFR1.
    Lam K; Rao VS; Qasba PK
    J Biomol Struct Dyn; 1998 Jun; 15(6):1009-27. PubMed ID: 9669548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare premalignant prostate tumor epithelial cell syndecan-1 forms a fibroblast growth factor-binding complex with progression-promoting ectopic fibroblast growth factor receptor 1.
    Wu X; Kan M; Wang F; Jin C; Yu C; McKeehan WL
    Cancer Res; 2001 Jul; 61(13):5295-302. PubMed ID: 11431373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain.
    Thompson LD; Pantoliano MW; Springer BA
    Biochemistry; 1994 Apr; 33(13):3831-40. PubMed ID: 8142385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
    Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
    Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican.
    Steinfeld R; Van Den Berghe H; David G
    J Cell Biol; 1996 Apr; 133(2):405-16. PubMed ID: 8609172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex.
    Wang F; Lu W; McKeehan K; Mohamedali K; Gabriel JL; Kan M; McKeehan WL
    Biochemistry; 1999 Jan; 38(1):160-71. PubMed ID: 9890894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix.
    Moscatelli D
    J Biol Chem; 1992 Dec; 267(36):25803-9. PubMed ID: 1464594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
    Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
    J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A protein canyon in the FGF-FGF receptor dimer selects from an à la carte menu of heparan sulfate motifs.
    Mohammadi M; Olsen SK; Goetz R
    Curr Opin Struct Biol; 2005 Oct; 15(5):506-16. PubMed ID: 16154740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic fibroblast growth factor binding and processing by human glioma cells.
    Murphy PR; Knee RS
    Mol Cell Endocrinol; 1995 Oct; 114(1-2):193-203. PubMed ID: 8674845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin is essential for a single keratinocyte growth factor molecule to bind and form a complex with two molecules of the extracellular domain of its receptor.
    Hsu YR; Nybo R; Sullivan JK; Costigan V; Spahr CS; Wong C; Jones M; Pentzer AG; Crouse JA; Pacifici RE; Lu HS; Morris CF; Philo JS
    Biochemistry; 1999 Feb; 38(8):2523-34. PubMed ID: 10029547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor.
    Jellinek D; Green LS; Bell C; Lynott CK; Gill N; Vargeese C; Kirschenheuter G; McGee DP; Abesinghe P; Pieken WA
    Biochemistry; 1995 Sep; 34(36):11363-72. PubMed ID: 7547864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished heparin binding of a basic fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction, and in vitro angiogenesis.
    Li LY; Safran M; Aviezer D; Böhlen P; Seddon AP; Yayon A
    Biochemistry; 1994 Sep; 33(36):10999-1007. PubMed ID: 7522051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence analyses and comparative modeling of fly and worm fibroblast growth factor receptors indicate that the determinants for FGF and heparin binding are retained in evolution.
    Nagendra HG; Harrington AE; Harmer NJ; Pellegrini L; Blundell TL; Burke DF
    FEBS Lett; 2001 Jul; 501(1):51-8. PubMed ID: 11457455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex.
    Venkataraman G; Raman R; Sasisekharan V; Sasisekharan R
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3658-63. PubMed ID: 10097093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin.
    Pellegrini L; Burke DF; von Delft F; Mulloy B; Blundell TL
    Nature; 2000 Oct; 407(6807):1029-34. PubMed ID: 11069186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding.
    Roghani M; Mansukhani A; Dell'Era P; Bellosta P; Basilico C; Rifkin DB; Moscatelli D
    J Biol Chem; 1994 Feb; 269(6):3976-84. PubMed ID: 8307953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor receptors 1 and 2 interact differently with heparin/heparan sulfate. Implications for dynamic assembly of a ternary signaling complex.
    Powell AK; Fernig DG; Turnbull JE
    J Biol Chem; 2002 Aug; 277(32):28554-63. PubMed ID: 12034712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound.
    Miao HQ; Ornitz DM; Aingorn E; Ben-Sasson SA; Vlodavsky I
    J Clin Invest; 1997 Apr; 99(7):1565-75. PubMed ID: 9120000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.